Systemic Therapy for Hepatocellular Carcinoma Guidelines Pocket Guide - Guideline Central

Systemic Therapy for Hepatocellular Carcinoma

American Gastroenterological AssociationPublished: June 14, 2022

A PDF version of this Pocket Guide is also available!
$9.95
  • Key Points 
  • Treatment Recommendations 
    • First-line Treatment for HCC in Patients With Preserved Liver Function
    • Second-line Treatment for Individuals With Disease Progression or Intolerance to First-line Systemic Therapy
    • Systemic Therapy for HCC in Patients With Poor Liver Function
    • Systemic Therapy for HCC as Adjuvant Therapy
  • Figure 
    • Systemic Therapy for Hepatocellular Carcinoma -- Clinical Decision Support Tool 
  • Table 
    • Implementation


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.